CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 57  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1079
LYS 10.0124
GLU 20.0284
LEU 30.0176
ARG 40.0256
CYS 50.0086
GLN 60.0074
CYS 70.0097
ILE 80.0560
LYS 90.0153
THR 100.0261
TYR 110.0152
SER 120.0370
LYS 130.0621
PRO 140.0651
PHE 150.0386
HIS 160.0279
PRO 170.0154
LYS 180.0176
PHE 190.0155
ILE 200.0056
LYS 210.0174
GLU 220.0176
LEU 230.0138
ARG 240.0129
VAL 250.0096
ILE 260.0120
GLU 270.0232
SER 280.0142
GLY 290.0127
PRO 300.0068
HIS 310.0112
CYS 320.0079
ALA 330.0335
ASN 340.0186
THR 350.0192
GLU 360.0078
ILE 370.0142
ILE 380.0127
VAL 390.0095
LYS 400.0182
LEU 410.0136
SER 420.0185
ASP 430.0278
GLY 440.0069
ARG 450.0118
GLU 460.0152
LEU 470.0104
CYS 480.0168
LEU 490.0178
ASP 500.0282
PRO 510.0256
LYS 520.0462
GLU 530.0188
ASN 540.0081
TRP 550.0171
VAL 560.0168
GLN 570.0176
ARG 580.0086
VAL 590.0187
VAL 600.0190
GLU 610.0226
LYS 620.0157
PHE 630.0150
LEU 640.0091
LYS 650.0180
ARG 660.0235
ALA 670.0329
GLU 680.1079
ASN 690.0619

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.